Resultado da Busca
Springer is best known for discovering the first integrins, LFA-1, and intercellular adhesion molecules (ICAMs), and for elucidating how these cell adhesion molecules function in the immune system. In recent years, Springer's research interest has expanded to malaria, transforming growth factor beta (TGF-β) signaling, and von ...
Timothy A. Springer, PhD. Latham Family Professor. Professor of Biological Chemistry and Molecular Pharmacology, Professor of Medicine, Harvard Medical School. Principal Investigator, Program in Cellular and Molecular Medicine, Division of Hematology/Oncology, Department of Medicine, Boston Children’s Hospital.
Latest News. [OPEN POSITION]: Postdoctoral Fellow. [CLOSED]: Research Assistant I (2024) [CLOSED]: Research Assistant I (2023) Tim Springer delivers UC Berkeley's MCB 2022 Commencement Address. Timothy A. Springer to Receive Biophysical Society’s 2022 Founders Award [Biophysical Society] [CLOSED]: Research Assistant I (2021) More.
Timothy Alan Springer is a professor of biological chemistry and molecular pharmacology at Harvard Medical School. He is a pioneer in the field of immunology and adhesion receptors, and has founded several biotechnology companies and patents.
Research. My lab studies receptor-ligand interactions and signal transmission across membranes. We use a wide range of structural, cell biological, and single molecule techniques to answer important questions relevant to immunology, hemostasis, mammalian biology, and human disease.
Timothy A. Springer is a professor of biological chemistry and molecular pharmacology at Harvard Medical School. He studies receptor-ligand interactions and signal transmission across membranes, with a focus on integrins, von Willebrand factor, TGF-β, and malaria proteins.
Timothy A. Springer. Latham Family Professor of Biological Chemistry and Molecular Pharmacology. We work on receptor-ligand interactions and signal transmission across membranes.
